Advisor Group’s Blonder Tongue Laboratories Inc BDR Stock Holding History

Advisor Group’s Portfolio BDR Stock Details BDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-1,000	Closed	–	–	4668
2016 Q2	$0	Buy	+1,000	New	+$407	﹤0.01%	4550

Other funds holding BDR

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TCM

Tufton Capital Management Hunt Valley, Maryland $550M AUM 24.82% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

AWW

Alan W. Weber $336M AUM 75.94% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Advisor Group's BDR Position: Q3 2016 in Review

Advisor Group sold out of Blonder Tongue Laboratories Inc (BDR) in Q3 2016, closing a stake of 1,000 shares.

Advisor Group first reported a position in BDR in Q2 2016 and held it in 1 quarter. The position peaked at $0 in Q2 2016. 10 funds tracked by Wall St. Rank hold BDR as of Q3 2016.

Advisor Group reported no remaining Blonder Tongue Laboratories Inc position as of Q3 2016 after selling out during the quarter.
Advisor Group sold 1,000 Blonder Tongue Laboratories Inc shares in Q3 2016.
Advisor Group first reported a position in Blonder Tongue Laboratories Inc in Q2 2016 and held it in 1 quarter.
Advisor Group's Blonder Tongue Laboratories Inc position peaked at $0 in Q2 2016.
10 funds tracked by Wall St. Rank held Blonder Tongue Laboratories Inc as of Q3 2016.

Based on Advisor Group's 13F filing for Q3 2016, filed 9 Nov 2016.